FDA allows Houston cancer doctor to resume drug trial

Federal regulators have lifted a partial hold on a clinical trial performed by Stanislaw

Clinical Research Project Manager - CCRPS

GoLocalProv FDA Closes Last Option for 20-Year-Old RI Cancer Patient Facing Death

Novartis challenges Pfizer with strong breast cancer drug data

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

Clinical Translation of Extracellular Vesicles - Ghodasara - 2023 - Advanced Healthcare Materials - Wiley Online Library

Ashish M. Kamat MD Anderson Cancer Center

When Cancer Patients Ask About Weed, Many Doctors Say Go For It – Houston Public Media

Doctor claims to cure pediatric cancer, critics skeptical

Coverage Analysis - Clinical Trials/Research (Setup) - Set Up - UTHealth Houston

Doctor claims to cure pediatric cancer, critics skeptical

FibroGen limited access to Duchenne muscular dystrophy drug after failed clinical trial. But mom says it works for her son. - San Francisco Business Times

Texas Medical Board sanctions controversial cancer doctor Burzynski

Kentucky kidney transplant patient wants trial after getting cancer

At the Bedside: New focal therapies at UTHealth Houston make prostate cancer treatment easier on patients - UTHealth News - UTHealth Houston

Hagop M. Kantarjian MD Anderson Cancer Center